Last update:

Weight management news

New obesity figures highlight the income divide

The number of obese adults in England rose from 26% in 2019 to 30% in 2025, according to a new analysis of 55 million people. Nearly 1 in 3 adults are now obese. But averages hide a lot, and behind this one are two very different ...

Vellore cohort reveals India's growing double burden of malnutrition in school-age children

Children growing up in a low-income urban community in Vellore are now facing two seemingly opposite forms of malnutrition simultaneously: persistent thinness and rising obesity by the time they reach primary school age. ...

7 things to know about Medicare's new GLP-1 coverage

For decades, it's been against the law for Medicare to pay for weight-loss medication. But that changed on July 1, with the launch of a new program called Bridge. It gives some people over 65, or who have Medicare for other ...

Stronger focus on nutrition needed in eating disorder recovery

Overreliance on body mass index (BMI) to measure recovery from eating disorders has sparked calls for better assessment methods. University of Queensland researchers reviewed 60 studies from five databases across 16 countries ...

Excess belly fat linked to faster biological aging

New research suggests that higher levels of visceral fat, the fat stored deep in the abdomen, could contribute to faster biological aging in middle-aged adults. Adjunct Associate Professors Jennie Hui and Kun Zhu, from The ...

Will GLP-1s lead to fewer prescriptions for older adults?

As people age, they often develop chronic conditions, many of which need to be managed with multiple prescription medications. While medications are important for disease management, polypharmacy poses an increased risk for ...

New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks

A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to a 12% reduction in body weight after 36 weeks, according to a randomized phase II clinical trial published in Nature ...